Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Young age may predict a better outcome for children with diffuse pontine glioma.

Broniscer A, Laningham FH, Sanders RP, Kun LE, Ellison DW, Gajjar A.

Cancer. 2008 Aug 1;113(3):566-72. doi: 10.1002/cncr.23584.

2.

Outcome analysis of childhood low-grade astrocytomas.

Fisher PG, Tihan T, Goldthwaite PT, Wharam MD, Carson BS, Weingart JD, Repka MX, Cohen KJ, Burger PC.

Pediatr Blood Cancer. 2008 Aug;51(2):245-50. doi: 10.1002/pbc.21563.

PMID:
18386785
3.

The 2007 WHO classification of tumours of the central nervous system.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P.

Acta Neuropathol. 2007 Aug;114(2):97-109. Epub 2007 Jul 6. Review. Erratum in: Acta Neuropathol. 2007 Nov;114(5):547.

4.

High-grade astrocytoma in very young children.

Sanders RP, Kocak M, Burger PC, Merchant TE, Gajjar A, Broniscer A.

Pediatr Blood Cancer. 2007 Dec;49(7):888-93.

PMID:
17554787
5.

Long-term survival in children under 3 years of age with low-grade astrocytoma.

Rivera-Luna R, Zapata-Tarrés M, Medina-Sansón A, López-Aguilar E, Niembro-Zúñiga A, Amador Zarco J, Marhx-Bracho A, Rueda-Franco F, Bornstein-Quevedo L.

Childs Nerv Syst. 2007 May;23(5):543-7. Epub 2007 Jan 17.

PMID:
17226033
6.

Treatment options in childhood pontine gliomas.

Wagner S, Warmuth-Metz M, Emser A, Gnekow AK, Sträter R, Rutkowski S, Jorch N, Schmid HJ, Berthold F, Graf N, Kortmann RD, Pietsch T, Sörensen N, Peters O, Wolff JE.

J Neurooncol. 2006 Sep;79(3):281-7. Epub 2006 Apr 6.

PMID:
16598416
7.
8.

International Classification of Childhood Cancer, third edition.

Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P.

Cancer. 2005 Apr 1;103(7):1457-67.

9.

Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.

Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C; French Society of Pediatric Oncology.

J Clin Oncol. 2003 Dec 15;21(24):4572-8.

PMID:
14673044
10.

Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.

Fouladi M, Hunt DL, Pollack IF, Dueckers G, Burger PC, Becker LE, Yates AJ, Gilles FH, Davis RL, Boyett JM, Finlay JL.

Cancer. 2003 Sep 15;98(6):1243-52.

11.

The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience.

Pollack IF, Boyett JM, Yates AJ, Burger PC, Gilles FH, Davis RL, Finlay JL; Children's Cancer Group.

Neuro Oncol. 2003 Jul;5(3):197-207.

12.

High response rate to cisplatin/etoposide regimen in childhood low-grade glioma.

Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, Riva D, Ruggiero A, Valentini L, Mazza E, Genitori L, Di Rocco C, Navarria P, Casanova M, Ferrari A, Luksch R, Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F.

J Clin Oncol. 2002 Oct 15;20(20):4209-16.

PMID:
12377964
13.

Preradiation chemotherapy for pediatric patients with high-grade glioma.

Wolff JE, Gnekow AK, Kortmann RD, Pietsch T, Urban C, Graf N, Kühl J.

Cancer. 2002 Jan 1;94(1):264-71.

14.

Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital.

Gajjar A, Sanford RA, Heideman R, Jenkins JJ, Walter A, Li Y, Langston JW, Muhlbauer M, Boyett JM, Kun LE.

J Clin Oncol. 1997 Aug;15(8):2792-9.

PMID:
9256121
15.

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM.

J Neurosurg. 1997 May;86(5):747-54.

PMID:
9126887
16.

Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.

Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA.

J Neurooncol. 1997 May;32(3):235-41.

PMID:
9049885
17.

Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience.

Duffner PK, Krischer JP, Burger PC, Cohen ME, Backstrom JW, Horowitz ME, Sanford RA, Friedman HS, Kun LE.

J Neurooncol. 1996 May-Jun;28(2-3):245-56. Review.

PMID:
8832466
18.

Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group.

Geyer JR, Finlay JL, Boyett JM, Wisoff J, Yates A, Mao L, Packer RJ.

Cancer. 1995 Feb 15;75(4):1045-50.

19.

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, et al.

J Clin Oncol. 1995 Jan;13(1):112-23.

PMID:
7799011
20.

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.

Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, Evans AE, Wara W, Hammond D.

J Neurooncol. 1989 Jul;7(2):165-77.

Supplemental Content

Support Center